Abstract:Precisely delivering combinational therapeutic agents has become a crucial challenge for anti-tumor treatment. In this study, a novel redox-responsive polymeric prodrug (MW: 93.5 kDa) was produced by reversible addition-fragmentation chain transfer (RAFT) polymerization. The amphiphilic block polymer-doxorubicin (DOX) prodrug was employed to deliver a hydrophobic photosensitizer (PS), chlorin e6 (Ce6), and the as-prepared nanoscale system [NPs(Ce6)] was investigated as a chemo-photodynamic anti-cancer agent. The glutathione (GSH)-cleavable disulfide bond was inserted into the backbone of the polymer for biodegradation inside tumor cells, and DOX conjugated onto the polymer with a disulfide bond was successfully released intracellularly. NPs(Ce6) released DOX and Ce6 with their original molecular structures and degraded into segments with low MWs of 41.2 kDa in the presence of GSH. NPs(Ce6) showed a chemo-photodynamic therapeutic effect to kill 4T1 murine breast cancer cells, which was confirmed from a collapsed cell morphology, a lifted level in the intracellular reactive oxygen species, a reduced viability and induced apoptosis. Moreover, ex vivo fluorescence images indicated that NPs(Ce6) retained in the tumor, and exhibited a remarkable in vivo anticancer efficacy. The combinational therapy showed a significantly increased tumor growth inhibition (TGI, 58.53%). Therefore, the redox-responsive, amphiphilic block polymeric prodrug could have a great potential as a chemo-photodynamic anti-cancer agent.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop a new type of polymer prodrug - based nanodrug system that responds to the tumor microenvironment for the combined anticancer treatment of chemotherapy and photodynamic therapy. Specifically, the researchers designed and synthesized a glutathione (GSH) - sensitive amphiphilic block polymer prodrug, which can load the hydrophobic photosensitizer chlorin e6 (Ce6). Through this design, the polymer prodrug can be specifically degraded within tumor cells, releasing the chemotherapeutic drug doxorubicin (DOX) and the photosensitizer Ce6, thereby achieving the synergistic effect of chemotherapy and photodynamic therapy and improving the killing effect on breast cancer cells. ### Main research contents: 1. **Design and synthesis of polymer prodrug**: - An amphiphilic block polymer prodrug with a high molecular weight (93.5 kDa) was synthesized using reversible addition - fragmentation chain transfer (RAFT) polymerization technology. - This polymer prodrug contains a GSH - cleavable disulfide bond, enabling it to be degraded in the reducing environment within tumor cells to release the drug. 2. **Preparation and characterization of nanoparticles**: - Blank nanoparticles (NPs) and Ce6 - loaded nanoparticles (NPs(Ce6)) were prepared by the thin - film hydration method. - The critical micelle concentration (CMC), particle size distribution, Zeta potential, and morphological structure of the nanoparticles were characterized. 3. **Drug - release characteristics**: - The drug - release behaviors of NPs and NPs(Ce6) in the presence of different pH values and GSH were studied. - The results showed that in the presence of GSH, the release rates of DOX and Ce6 increased significantly, indicating that the polymer prodrug can effectively respond and release the drug in the tumor microenvironment. 4. **In vitro cell experiments**: - The antitumor effects of NPs(Ce6) in 4T1 mouse breast cancer cells were evaluated through cell uptake experiments, photoswitch cytotoxicity experiments, and photodynamic therapy (PDT) experiments. - The experimental results showed that NPs(Ce6) can be effectively taken up by cells and generate singlet oxygen (1O2) under light conditions, leading to cell apoptosis and a decrease in cell survival rate. 5. **In vivo antitumor effects**: - The in vivo antitumor effects of NPs(Ce6) were evaluated in a tumor - bearing mouse model. - The results showed that NPs(Ce6) can significantly inhibit tumor growth, with a tumor growth inhibition rate (TGI) reaching 58.53%. ### Conclusion: This study successfully developed a GSH - sensitive amphiphilic block polymer prodrug - based nanodrug system. This system can effectively load the chemotherapeutic drug DOX and the photosensitizer Ce6, and achieve the specific release of drugs by responding to the high GSH concentration in the tumor microenvironment, thereby enhancing the synergistic antitumor effects of chemotherapy and photodynamic therapy. This research result provides new ideas for developing new combined anticancer treatment strategies.

GSH-sensitive polymeric prodrug: Synthesis and loading with photosensitizers as nanoscale chemo-photodynamic anti-cancer nanomedicine

GSH-sensitive Polymeric Prodrug:Synthesis and Loading with Photosensitizers As Nanoscale Chemo-Photodynamic Anti-Cancer Nanomedicine

GSH-responsive Prodrug-Based Nanodrugs for Augmenting Chemo-Photodynamic Synergistic Therapy Against Tumors

H2O2-responsive polymer prodrug nanoparticles with glutathione scavenger for enhanced chemo-photodynamic synergistic cancer therapy

Bioresponsive Prodrug Nanogel-Based Polycondensate Strategy Deepens Tumor Penetration and Potentiates Oxidative Stress

Multi-stimuli responsive polymeric prodrug micelles for combined chemotherapy and photodynamic therapy

Preparation of GSH-responsive nanoparticles for combined chemo-photothermal therapy codelivering 6-MP and Ce6

Oxidation-strengthened disulfide-bridged prodrug nanoplatforms with cascade facilitated drug release for synergetic photochemotherapy

Enhanced Photodynamic Therapy Based on an Amphiphilic Branched Copolymer with Pendant Vinyl Groups for Simultaneous GSH Depletion and Ce6 Release.

Tumor-specific carrier-free nanodrugs with GSH depletion and enhanced ROS generation for endogenous synergistic anti-tumor by a chemotherapy-photodynamic therapy

An intracellular enzyme-responsive polymeric prodrug with synergistic effect of chemotherapy and two-photon photodynamic therapy

Photosensitizer (ps)/polyhedral Oligomeric Silsesquioxane (Poss)-Crosslinked Nanohybrids for Enhanced Imaging-Guided Photodynamic Cancer Therapy.

Polyphotosensitizer nanogels for GSH-responsive histone deacetylase inhibitors delivery and enhanced cancer photodynamic therapy

Biodegradable polyphosphazene-based nanodrug to regulate redox homeostasis for augmented chemo-photodynamic therapy

A pH-sensitive supramolecular nanosystem with chlorin e6 and triptolide co-delivery for chemo-photodynamic combination therapy

Development of Redox-Responsive Theranostic Nanoparticles for Near-Infrared Fluorescence Imaging-Guided Photodynamic/chemotherapy of Tumor

Glutathione Activatable Photosensitizer-Conjugated Pseudopolyrotaxane Nanocarriers for Photodynamic Theranostics.

Ph/redox Dual-Stimuli-responsive Cross-Linked Polyphosphazene Nanoparticles for Multimodal Imaging-Guided Chemo-Photodynamic Therapy

Photodynamic Therapy-Triggered On-Demand Drug Release from ROS-responsive Core-Cross-linked Micelles Toward Synergistic Anti-Cancer Treatment

Smart Unimolecular Micelles-based Polyprodrug with Dual Redox Stimuli-Response for Tumor Microenvironment: Enhanced In Vivo Delivery Efficiency and Tumor Penetration.

Dendritic Nanoconjugates of Photosensitizer for Targeted Photodynamic Therapy